Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dorie A. Sher
Observed names:
D. A. Sher,
Dorie A Sher,
Sher, D.A.
Institution:
Washington University in St. Louis
Observed institutions:
Washington University in St. Louis,
University of Illinois Chicago,
University of Chicago,
Eastern Cooperative Oncology Group,
University of Chicago Medical Center,
National Cancer Institute,
The Ohio State University
show all 7
OpenAlex ID:
A5111569805
Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
2013
·
Catherine E. Cottrell
, Hussam Al-Kateb
, et al.
·
Journal of Molecular Diagnostics
·
184
PDF
Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity
2005
·
Guido Marcucci
, Wendy Stock
, et al.
·
Journal of Clinical Oncology
·
142
PDF
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia
2012
·
Robert E. Gallagher
, Barry K. Moser
, et al.
·
Blood
·
57
PDF
Interaction of p59fynwith Interferon-Activated Jak Kinases
1997
·
Shahab Uddin
, Dorie A. Sher
, et al.
·
Biochemical and Biophysical Research Communications
·
43
Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads
2005
·
Ding Wu
, Evan Nair-Gill
, et al.
·
Analytical Biochemistry
·
11
Autologous Stem Cell Transplantation (SCT) Following Sequential Chemotherapy and Imatinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) — CALGB Study 10001.
2007
·
Meir Wetzler
, Wendy Stock
, et al.
·
Blood
·
5
PML-RARα isoform at diagnosis is associated with disease-free survival (DFS) in patients enrolled in the intergroup trial (C-9710) for treatment of acute promyelocytic leukemia (APL)
2006
·
W. Stock
, B. Moser
, et al.
·
Journal of Clinical Oncology
·
3
Abl Kinase Domain Mutations Leading to Relapse of Ph+ Acute Lymphoblastic Leukemia (ALL) Occur Commonly and Can Be Detected At Initial Diagnosis: Molecular Results From CALGB 10001
2011
·
Gregory Koval
, Meir Wetzler
, et al.
·
Blood
·
1
Results of An International Study of Quantitative BCR/ABL Assays Using Defined RNA Samples
2010
·
Dorie A. Sher
, Jeffrey E. Miller
, et al.
·
Blood
·
1
Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.
2010
·
Robert E. Gallagher
, Barry K. Moser
, et al.
·
Blood
Results of An International Study of Quantitative BCR/ABL Assays Using Defined RNA Samples
2010
·
Sher, D.A.
, Miller, J.E.
, et al.
·
IRIS
Show more works
View as search
Works count:
11
Citation count:
447
H-index:
5
I10-index:
5
Year
Topic
Type